Sceaux, France

Michel Fardeau


Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1997-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michel Fardeau: Innovator in Muscular Dystrophy Research

Introduction

Michel Fardeau is a prominent inventor based in Sceaux, France. He has made significant contributions to the field of muscular dystrophy research, particularly in the diagnosis and understanding of various forms of this condition. With a total of 2 patents to his name, Fardeau's work has the potential to impact the lives of many individuals affected by muscular dystrophy.

Latest Patents

Fardeau's latest patents include a method for aiding in the diagnosis of merosin deficiency-type congenital muscular dystrophy (CMD). This method is based on the discovery of a previously unidentified form of CMD, characterized by a substantial reduction in the levels of merosin in skeletal muscle tissue that contains normal levels of dystrophin and dystrophin-associated proteins. Another significant patent involves a substantially pure nucleic acid sequence encoding a mammalian 43 kDa non-dystrophin component, known as β-sarcoglycan, of the dystrophin-glycoprotein complex. This patent also discloses immunogenic peptides that stimulate the production of antibodies specifically binding to β-sarcoglycan. Furthermore, it identifies mutations in the β-sarcoglycan gene associated with autosomal recessive limb-girdle muscular dystrophy, enabling the design of nucleic acid probes for diagnosis.

Career Highlights

Michel Fardeau is affiliated with the University of Iowa Research Foundation, where he continues to advance his research in muscular dystrophy. His work has garnered attention for its innovative approach to understanding and diagnosing these complex conditions.

Collaborations

Fardeau has collaborated with notable researchers in the field, including Kevin P. Campbell and Yoshihide Sunada. Their combined expertise has contributed to the advancement of knowledge in muscular dystrophy research.

Conclusion

Michel Fardeau's contributions to the field of muscular dystrophy research through his patents and collaborations highlight his commitment to improving diagnosis and understanding of these conditions. His work continues to pave the way for future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…